Sort by
Refine Your Search
-
Country
-
Program
-
Employer
- RMIT University
- University of British Columbia
- ;
- University of Oslo
- ; University of Southampton
- ; University of Warwick
- Academic Europe
- CK-CARE AG
- Christine Kühne – Center for Allergy Research and Education (CK-CARE)
- Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- KNAW
- Karolinska Institutet
- Leibniz
- Leiden University Medical Center (LUMC)
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Munich
- University Medical Centre Groningen (UMCG)
- University of Basel
- iBET - Instituto de Biologia Experimental e Tecnológica
- 14 more »
- « less
-
Field
-
at the Department of Biomedicine (“Cancer Immunology”) and PD Dr. Matter at the Department of Pathology are seeking a highly motivated PhD candidate with scientific interest in Cancer Immunology & Immunotherapy
-
. The Applied Immunology & Immunotherapy group is physically located at the Centre for Molecular Medicine, a translational medical centre, and the research focus is developing innovative ways to treat chronic
-
10 Feb 2024 Job Information Organisation/Company Radboud University Medical Center (Radboudumc) Research Field Medical sciences Physics Researcher Profile First Stage Researcher (R1) Country Netherlands Application Deadline 10 Mar 2024 - 23:00 (UTC) Type of Contract Temporary Job Status Not...
-
Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association | Dresden, Sachsen | Germany | about 1 month ago
employment. Starting date: 01.06.2024 Job description:PhD Student (f/m/d) Pre-clinical development and validation of Adapter-RevCAR‐T-cell-system for immunotherapy of melanoma With cutting-edge research in
-
immunotherapies to fight diseases such as cancer. We are currently advertising a PhD position in this area (funded by an EPSRC DTP Studentship) in the Dept. of Chemistry at Warwick co-supervised by Dr Ann Dixon and
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy
-
biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks to exploit tumor-specific glycosylation
-
position within a Research Infrastructure? No Offer Description The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on
-
such as immunotherapies are revolutionising cancer treatment. However, as they are not effective in all patients they should be tailored to the right patients while work to identify new drug targets and